How effective is a 2-year peer-support diabetes education program, for type 2 diabetes, in a semi-rural Mayan community in the Yucatán, Mexico?

Effectiveness of a 2-year peer support diabetes education intervention, for type 2 diabetes, implemented in a semi-rural Mayan community in the Yucatán, Mexico: A randomised clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN96897082

Enrollment

152

Registered

2020-07-07

Start date

2017-08-16

Completion date

Unknown

Last updated

2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

This is a trial with a 2-year duration for participants with a previous diagnosis of type 2 diabetes, recruited from the community clinics in Conkal, Yucatán. Participants will be ass

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of type 2 diabetes mellitus 2. Aged =30 years 3. Identified in community health centers of Conkal, Yucatán 4. Wish to participate in the study

Exclusion criteria

Exclusion criteria: 1. Diagnosis of physical disabilities and cannot be displaced from their homes 2. Diagnosis of a mental illness or severe learning difficulties 3. Pregnancy

Design outcomes

Primary

Measure	Time frame
Metabolic control assessed using glycated haemoglobin level (HbA1c) measured from blood samples taken at baseline, 4, 8, 12, 16, 20 and 24 months	—

Secondary

Measure	Time frame
1. Quality of life measured using the SF-36 Health Survey at baseline, 12, and 24 months 2. Systolic and diastolic blood pressure measured using an average of two readings measured on an OMRON HEM-7220 Automatic BP monitor at baseline, 4, 8, 12, 16, 20 and 24 months 3. Body Mass Index (BMI) calculated from weight, which was measured on an OMRON F514 balance, and height, which was measured on a SECA 213 Mobile Stadiometer, at baseline, 4, 8, 12, 16, 20 and 24 months 4. Self-reported use of diabetes-related self-care behaviors measured using the Summary of Diabetes Self-Care Activities Measure (SDSCA) at baseline, 12, and 24 months	—

Measure

Time frame

1. Quality of life measured using the SF-36 Health Survey at baseline, 12, and 24 months 2. Systolic and diastolic blood pressure measured using an average of two readings measured on an OMRON HEM-7220 Automatic BP monitor at baseline, 4, 8, 12, 16, 20 and 24 months 3. Body Mass Index (BMI) calculated from weight, which was measured on an OMRON F514 balance, and height, which was measured on a SECA 213 Mobile Stadiometer, at baseline, 4, 8, 12, 16, 20 and 24 months 4. Self-reported use of diabetes-related self-care behaviors measured using the Summary of Diabetes Self-Care Activities Measure (SDSCA) at baseline, 12, and 24 months

—

Countries

Mexico

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026